(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SCIENTURE PRIORITIZING PATIENTS. IMPROVING OUTCOMES.

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

SCIENTURE PRIORITIZING PATIENTS. IMPROVING OUTCOMES.

ST13

US500000088873539

Class

42

Filing

88873539

Registration

6610590

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

34

Latest update

11/27/2024

Trademark type

Combined

Nice classes

42

Filing date

04/15/2020

Registration date

01/11/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/11/2022

Last transaction

06/20/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

2020-02-00

First use in commerce

2020-02-00

Drawing code

3

Owner type

16

Owner location

COMMACK, NY

Examiner

NEVILLE, BRIAN

Law office

M50

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of circular designs forming a square shape to the left of the word "scienture" in larger font above the words "Prioritizing Patients. Improving Outcomes." in smaller font.

Holders and representatives

Holders

SCIENTURE, LLC
Scienture Inc.
Scienture Inc.

Representatives

Jessica L Rothstein GOODWIN PROCTER LLP

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Identifying and developing of innovative technology-based concepts for creating pharmaceutical products; Pharmaceutical research and development (R and D) providing medical and therapeutic research and development in multiple therapeutic areas in particular Central Nervous System (CNS)Cardiovascular System (CVS) and Oncology

Publications

History of USPTO decisions and trademark events.

34 publications found

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

11/27/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/20/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/20/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/20/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

06/20/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

06/20/2024

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

09/20/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

01/11/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/26/2021

PUBO

PUBLISHED FOR OPPOSITION

10/26/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/06/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/22/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/08/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/08/2021

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

09/08/2021

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

06/23/2021

GNFR

FINAL REFUSAL E-MAILED

06/23/2021

CNFR

FINAL REFUSAL WRITTEN

06/23/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/21/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/21/2021

ALIE

ASSIGNED TO LIE

05/12/2021

NREV

NOTICE OF REVIVAL - E-MAILED

02/02/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/01/2021

PETG

PETITION TO REVIVE-GRANTED

02/01/2021

PROA

TEAS PETITION TO REVIVE RECEIVED

02/01/2021

MAB2

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

01/29/2021

ABN2

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

01/29/2021

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

07/13/2020

GNRT

NON-FINAL ACTION E-MAILED

07/13/2020

CNRT

NON-FINAL ACTION WRITTEN

07/13/2020

DOCK

ASSIGNED TO EXAMINER

07/06/2020

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

04/24/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/23/2020

NWAP

NEW APPLICATION ENTERED

04/18/2020

Continuous trademark protection

Get notified about every new filing that threatens SCIENTURE PRIORITIZING PATIENTS. IMPROVING OUTCOMES. or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.